Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dejun Shen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biomarker Insights|August 8, 2009
Proteomics and mass spectrometry for cancer biomarker discoveryMing Lu, Kym F Faull, Julian P Whitelegge, et al.
International Journal of Oncology|September 3, 2009
Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapyJianbo He, Dejun Shen, Debra U Chung, et al.
Human Pathology|September 5, 2006
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysisDejun Shen, Farzad Nooraie, Yahya Elshimali, et al.
Scientific Reports|June 11, 2016
A microscopic landscape of the invasive breast cancer genomeZheng Ping, Yuchao Xia, Tiansheng Shen, et al.
International Journal of Oncology|December 5, 2006
Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometryJianbo He, Jeffrey Gornbein, Dejun Shen, et al.
International Journal of Proteomics|November 24, 2011
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic responseJianbo He, Stephen A Whelan, Ming Lu, et al.
Human Pathology|November 17, 2010
Higher levels of GATA3 predict better survival in women with breast cancerNam K Yoon, Erin L Maresh, Dejun Shen, et al.
Biochemical and Biophysical Research Communications|November 30, 2004
Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analysesDejun Shen, Helena R Chang, Zugen Chen, et al.
Cancer Research|December 4, 2010
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancersChuanwei Yang, Tetsu Hayashida, Nicole Forster, et al.
Breast Cancer Research : BCR|March 15, 2012
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study IIMegan S Rice, Rulla M Tamimi, James L Connolly, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biomarker Insights|August 8, 2009
Proteomics and mass spectrometry for cancer biomarker discoveryMing Lu, Kym F Faull, Julian P Whitelegge, et al.
International Journal of Oncology|September 3, 2009
Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapyJianbo He, Dejun Shen, Debra U Chung, et al.
Human Pathology|September 5, 2006
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysisDejun Shen, Farzad Nooraie, Yahya Elshimali, et al.
Scientific Reports|June 11, 2016
A microscopic landscape of the invasive breast cancer genomeZheng Ping, Yuchao Xia, Tiansheng Shen, et al.
International Journal of Oncology|December 5, 2006
Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometryJianbo He, Jeffrey Gornbein, Dejun Shen, et al.
International Journal of Proteomics|November 24, 2011
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic responseJianbo He, Stephen A Whelan, Ming Lu, et al.
Human Pathology|November 17, 2010
Higher levels of GATA3 predict better survival in women with breast cancerNam K Yoon, Erin L Maresh, Dejun Shen, et al.
Biochemical and Biophysical Research Communications|November 30, 2004
Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analysesDejun Shen, Helena R Chang, Zugen Chen, et al.
Cancer Research|December 4, 2010
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancersChuanwei Yang, Tetsu Hayashida, Nicole Forster, et al.
Breast Cancer Research : BCR|March 15, 2012
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study IIMegan S Rice, Rulla M Tamimi, James L Connolly, et al.
Pageof 3